We are proud to announce that our team of researchers has been selected to present a scientific poster at the prestigious 2024 ASCO (American Society of Clinical Oncology) Annual Meeting in Chicago, May 31-June 4, 2024. The poster, titled "Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates,"showcases our latest advancements in the field of breast cancer diagnostics and treatment.
In a recent preprint published on bioRxiv, researchers from Memorial Sloan Kettering Cancer Center, the Technical University of Dresden, the European Institute of Oncology, MultiplexDX and other institutions report on the development of multimodal histopathologic models that can stratify hormone receptor-positive early breast cancer.
We are excited to announce the publication of a groundbreaking study by our team of researchers in the preprint server medRxiv. The study, titled "Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates", presents a novel approach that significantly advances breast cancer diagnostics and treatment prediction.
